SDZ logo

Sandoz Group Stock Price

Symbol: SWX:SDZMarket Cap: CHF 19.7bCategory: Pharmaceuticals & Biotech

SDZ Share Price Performance

CHF 45.73
11.08 (31.98%)
38.5% overvalued intrinsic discount
CHF 33.01
Fair Value
CHF 45.73
11.08 (31.98%)
38.5% overvalued intrinsic discount
CHF 33.01
Fair Value
Price CHF 45.73
SwissSimon CHF 33.01

SDZ Community Narratives

SW
SwissSimon·Updated
Fair Value CHF 33.01 38.5% overvalued intrinsic discount

SDZ: fairly priced according to analysts

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

SDZ Community Fair Values

Recent SDZ News & Updates

No updates

Sandoz Group AG Key Details

US$10.4b

Revenue

US$5.5b

Cost of Revenue

US$4.9b

Gross Profit

US$4.9b

Other Expenses

US$0

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Aug 07, 2025
Earnings per share (EPS)
0
Gross Margin
47.44%
Net Profit Margin
0%
Debt/Equity Ratio
55.5%

Sandoz Group AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About SDZ

Founded
1886
Employees
22049
CEO
Richard Saynor
WebsiteView website
www.sandoz.com

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Swiss Market Performance

  • 7 Days: -1.1%
  • 3 Months: -2.0%
  • 1 Year: 3.1%
  • Year to Date: 2.0%
Over the last 7 days, the market has dropped 1.1%, driven by a loss of 1.4% in the Healthcare sector. As for the longer term, the market has actually risen by 3.1% in the last year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading